KRAS mutation-induced upregulation of PD-L1 mediates immune escape in human lung adenocarcinoma-Reference-Cited by-同舟云学术

KRAS mutation-induced upregulation of PD-L1 mediates immune escape in human lung adenocarcinoma

Published:2017-04-27 Issue:9 Volume:66 Page:1175-1187
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Chen Nan,Fang Wenfeng,Lin Zhong,Peng Peijian,Wang Juan,Zhan Jianhua,Hong Shaodong,Huang Jiaxing,Liu Lin,Sheng Jin,Zhou Ting,Chen Ying,Zhang Hongyu,Zhang Li

Funder

Chinese National Natural Science Foundation

Open project of State Key laboratory of Oncology in South China

Medical Scientific Research Fund of Guangdong Province

Young Teacher Training Program of Sun Yat-Sen University

Medical Scientific Research Found of ZhuHai City

CSCO-Hengrui Cancer Research Fund

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/article/10.1007/s00262-017-2005-z/fulltext.html

Reference38 articles.

1. Siegel RL, Miller KD, Jemal A (2015) Cancer statistics, 2015. CA Cancer J Clin 65(1):5–29. doi: 10.3322/caac.21254

2. Rothschild SI (2015) Targeted therapies in non-small cell lung cancer-beyond EGFR and ALK. Cancers 7(2):930–949. doi: 10.3390/cancers7020816

3. Sholl LM, Aisner DL, Varella-Garcia M et al (2015) Multi-institutional oncogenic driver mutation analysis in lung adenocarcinoma: the lung cancer mutation consortium experience. J Thorac Oncol 10(5):768–777. doi: 10.1097/jto.0000000000000516

4. Kris MG, Johnson BE, Berry LD et al (2014) Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs. JAMA 311(19):1998–2006. doi: 10.1001/jama.2014.3741

5. Leduc C, Besse B (2015) Targeted therapies in non-small cell lung cancer in 2014. Rev Mal Respir 32(2):182–192. doi: 10.1016/j.rmr.2014.08.014

Cited by 217 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fingerprint Profiling of Glycans on Extracellular Vesicles via Lectin-Induced Aggregation Strategy for Precise Cancer Diagnostics;Journal of the American Chemical Society;2024-09-05

2. A Novel Monoclonal Antibody against PD-1 for the Treatment of Viral Oncogene-Induced Tumors or Other Cancer;Cancers;2024-09-01

3. CRISPR/Cas-Mediated Knockdown of PD-L1 and KRAS in Lung Cancer Cells;International Journal of Molecular Sciences;2024-08-22

4. MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancer;Signal Transduction and Targeted Therapy;2024-08-21

5. Current perspectives of KRAS in non-small cell lung cancer;Current Problems in Cancer;2024-08